2017 Multiple Myeloma Rounds

2017 Multiple Myeloma Rounds

             We are excited to announce the formation of the 2017 Multiple Myeloma Rounds!

                Please Join us at one of these Free CME/CE Accredited Dinner Programs in your area!

In 2016, Dr. Agne Paner and her colleagues at several institutions in the Chicago area joined together to form the Chicago Multiple Myeloma Rounds Committee. Their collaborative effort led to the implementation of four Multiple Myeloma Rounds programs that were held in the Chicago area in 2016.

As a result of the success of the Chicago Multiple Myeloma Rounds, the Committee decided to expand the program to other multiple myeloma communities around the country.  

We are pleased that in 2017 the Multiple Myeloma Rounds program has now grown to include a Committee of 36 multiple myeloma specialists from 24 different institutions who will be implementing the Multiple Myeloma Rounds program in 5 cities across the country!

This program will continue to provide a forum for local healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their multiple myeloma patients.  

The Multiple Myeloma Rounds provides an opportunity for participants to exchange information, network with their colleagues, share best practices and learn the latest information on new therapies and advances in the management of multiple myeloma through interactive case studies presented by experts in the local area.

Please join us at one of the upcoming events!

The 2017 Multiple Myeloma Rounds Program Chairs and Committee Members

Chicago Multiple Myeloma Rounds Founding Chair and CME Course Director:
Agne Paner, MD Rush University

2017 Chicago Multiple Myeloma Rounds Regional Chairpersons
(A complete list of all 2017 Committee Members can be found on tab at top of page)

Ajay K. Nooka, MD, MPH, FACP Winship Cancer Institute Emory University
Agne Paner, MD Rush University
Melissa Alsina, MD, Rachid Baz, MD, and Kenneth H. Shain, MD Moffitt Cancer Center
Ola Landgren, MD and Neha S. Korde, MD Memorial Sloan Kettering Cancer Center
William Bensinger, MD Swedish Cancer Institute

 logo colors 04 text at bottomsmall           
12 252 LRF Final Logo             Plexus logo 1.28           Rush Logo MasterBrndTransparent                                      



Accreditation Information: 

In support of improving patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.


Rush University Medical Center designates this Live Activity for a maximum of two (2) AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 


Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this live activity for two (2) Continuing Education credits. This activity will fulfill Category 2 contact hour requirements for pharmacology for ANCC certified advanced practice nurses. 


This program is approved for 2.0 hours (0.2 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.

There is no fee for participating in this activity.

Educational Objectives:

1.  Distinguish among the biologic and molecular mechanisms involved in the pathology of MM as it relates to therapeutic targets and treatment selection

2.  Appraise conventional, newly approved, and emerging therapies thathave the potential to enhance clinical outcomes

3.  Identify disease- and therapy-associated adverse events and utilize evidence-based management strategies

4.  Devise optimal evidence-based strategies for individualized treatment

5. Identify limitations and controversies in the standard of care treatment in MM, and how these pertain to individual patient management

Multiple Myeloma Rounds-2017: Treatment of Multiple Myeloma in a Rapidly Evolving Therapeutic Landscape: Application to Current Practice is supported by an educational grant from AbbVie, Amgen, Celgene Corporation, Incyte Corporation, Janssen Biotech, Inc., and Merck
Date: Tuesday, October 17, 2017
Location: Atlanta Marriott Buckhead Hotel
                 3405 Lenox Rd NE, Atlanta, GA
Time: 5:30pm-8:30pm

Image result for atlanta marriott buckhead


5:30 pm: Exhibits/Registration/Dinner

6:15 pm: Opening Remarks
Ajay Nooka, MD:Atlanta Multiple Myeloma Rounds Program Chair   

6:30 pm: Introduction of Case #1: Newly Diagnosed Patient: Transplant Ineligible
Brion Randolph, MD: Cancer Treatment Centers of America

7:00 pm: Introduction of Case #2: Transplant-Eligible Patient: Optimizing Timing and Treatment
Ha Tran, MD: Piedmont Cancer Institute

7:30 pm: Introduction of Case #3: Refractory Patient: Management with FDA-Approved Agents
Ajay Nooka, MD:Emory University Winship Cancer Institute

8:00 pm: Introduction of Case #4: Relapsed Patient: First Relapse and Beyond
Scott R. Solomon, MD: The Blood and Marrow Transplant Group of Georgia

8:30 pm: Closing Remarks/Additional Discussion
The Atlanta Multiple Myeloma Rounds Committee

2017 Atlanta Multiple Myeloma Rounds Committee:

Emory University:
     Ajay Nooka, MD, MPH, FACP (Program Chair)

Cancer Treatment Centers of America: 
     Brion V. Randolph, MD

Georgia Cancer Specialists: 
     Kathleen Lambert, MD
     Lynn Zemsky, MD

Northwest Georgia Oncology Centers:
    Michael B. Andrews, MD

Piedmont Cancer Institute: 
     Ha Tran, MD

Suburban Hematology-Oncology Associates:
     P. Ravi Sarma, MD, FACP

The Blood and Marrow Transplant Group of Georgia

     Asad Bashey, MD, PhD
    Scott R. Solomon, MD


Date: Wednesday, November 15, 2017
Location: The Hyatt Lodge at McDonald's Campus

                  2815 Jorie Blvd
                  Oak Brook, IL
Time: 5:30pm-8:30pm

Image result for hyatt lodge at mcdonald's campus


5:30pm- Exhibits/Registration/Dinner

6:15pm- Opening Remarks

6:30pm- Introduction of Case #1: Transplant in Relapsed Disease
               Presented by: Medical College of Wisconsin

7:10pm- Introduction of Case #2: Management of Late Relapsed Disease
               Presented by: Rush University Medical Center

7:50pm- Introduction of Case #3: Management of Early Relapsed Myeloma Progressing on Lenalidomide Maintenance
               Presented by: University of Illinois Medical Center

8:30pm- Closing Remarks/Additional Discussion

2017 Chicago Multiple Myeloma Rounds Committee 

Loyola University Medical Center:
Kevin Barton, MD

Advocate Lutheran General Hospital:
Tulio Rodriguez, MD

Medical College of Wisconsin:
Binod Dhakal, MD
     Parameswaran Hari, MD

Rush University Medical Center:
Agne Paner, MD, (Program Chair), Parameswaran Venugopal, MD, and John Maciejewski, MD

John H. Stroger, Jr Hospital of Cook County:
David Sumoza, MD    

University of Illinois at Chicago Medical Center:

    Pritesh Patel, MD

2017 Florida Multiple Myeloma Rounds Committee

Moffitt Cancer Center:
    Melissa Alsina, MD, Rachid Baz, MD, and Kenneth H. Shain, MD

2017 NYC/NJ Multiple Myeloma Rounds Committee

Memorial Sloan Kettering Cancer Center:
       Ola Landgren, MD (Program Chair)

Columbia University Medical Center:
       Suzanne Lentzsch, MD

Hackensack Medical Center:
        David Siegel, MD, Joshua Richter, MD, Noa Biran, MD

Memorial Sloan Kettering Cancer Center:
        Neha S. Korde, MD

Mount Sinai Hospital:
       Sundar Jagannath, MD

Weill Cornell Medical Center:
       Ruben Niesvizky, MD, Roger N. Pearse, MD, Adriana Rossi, MD, Cara Rosenbaum, MD

Date: Thursday, November 16, 2017
Location: Sorrento Hotel
                 900 Madison St
                 Seattle, WA
Time: 6:00pm-8:30pm

Image result for sorrento , seattle


5:30pm        Exhibits/Registration/Dinner

6:00pm        Opening Remarks

6:30pm        Introduction of Case #1: Minimal Residual Disease and Detection

7:10pm        Introduction of Case #2: Maintenance Therapy: Standard vs. High-Risk

7:50pm        Introduction of Case #3: Bloodless Transplants

8:30pm        Closing Remarks/Additional Discussion

2017 Seattle Multiple Myeloma Rounds Committee

Swedish Cancer Institute:
     William Bensinger, MD (Program Chair)

Fred Hutchinson Cancer Center:
     Damian Green, MD

Seattle Cancer Care Alliance:
      Edward Libby, MD

Swedish Cancer Institute:
      Ami Batchelder, PA-C

The 2017 Multiple Myeloma Rounds program is proudly endorsed by:
The Leukemia Foundation
The Amyloidosis Foundation

LRF Logo high res    logo colors 04 text at bottomsmall
If your company is interested in exhibiting at any of these events, please contact us at:

E-mail: mmrounds@plexuscomm.com

Phone: 1-866-607-4333
To register for one of the programs.. please click "REGISTER"

Categories: Symposia